VRTXEarnings Release财报快讯Media source媒体来源Source link原始来源August 3, 20262026/8/3by InvestLog AIInvestLog AI 整理

VRTX earnings release — EPS in line -0.2% · revenue beat +3.1%福泰制药 (VRTX) 财报发布 — EPS 基本符合预期-0.2% · 营收高于预期+3.1%

Key Results

Vertex Pharmaceuticals Incorporated (VRTX) published results at 2026-08-03 16:01:00.

EPS: $4.73 vs $4.74 estimate, in line-0.2%.

Revenue: $3.3B vs $3.2B estimate, beat+3.1%.

Period: 2026 Q2 period ended 2026-06-30

Revenue: $3.3B; YoY: +12.5%; QoQ: +11.6%

Gross profit: $2.8B; Gross margin: 85.3%

Operating income: $1.2B; Operating margin: 37.4%; YoY: +8.3%; QoQ: +9.6%

Net income: $1.1B; GAAP diluted EPS: $4.31; YoY: +6.5%; QoQ: +6.6%

Cash: $0; Total debt: $2.0B; Net debt: $2.0B

Official release: Vertex Reports Second Quarter 2026 Financial Results

福泰制药 (VRTX) 已发布财报，发布时间：2026-08-03 16:01:00。

EPS：$4.73 vs $4.74 预期，基本符合预期-0.2%。

营收：$3.3B vs $3.2B 预期，高于预期+3.1%。

期间：2026 Q2 period ended 2026-06-30

营收：$3.3B；同比：+12.5%；环比：+11.6%

毛利润：$2.8B；毛利率：85.3%

经营利润：$1.2B；经营利润率：37.4%；同比：+8.3%；环比：+9.6%

净利润：$1.1B；GAAP 稀释 EPS：$4.31；同比：+6.5%；环比：+6.6%

现金：$0；总债务：$2.0B；净债务：$2.0B

官方公告：Vertex Reports Second Quarter 2026 Financial Results

For information only. Not investment advice.内容仅供参考，不构成投资建议。